Association of the Gut Microbiota With Cognitive Function in Midlife.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
    • Publication Information:
      Original Publication: Chicago, IL : American Medical Association, [2018]-
    • Subject Terms:
    • Abstract:
      Importance: Animal experiments and small clinical studies support a role for the gut microbiota in cognitive functioning. Few studies have investigated gut microbiota and cognition in large community samples.
      Objective: To examine associations of gut microbial composition with measures of cognition in an established population-based study of middle-aged adults.
      Design, Setting, and Participants: This cross-sectional study analyzed data from the prospective Coronary Artery Risk Development in Young Adults (CARDIA) cohort in 4 US metropolitan centers between 2015 and 2016. Data were analyzed in 2019 and 2020.
      Exposures: Stool DNA were sequenced, and the following gut microbial measures were gathered: (1) β-diversity (between-person) derived with multivariate principal coordinates analysis; (2) α-diversity (within-person), defined as richness (genera count) and the Shannon index (integrative measure of genera richness and evenness); and (3) taxonomy (107 genera, after filtering).
      Main Outcomes and Measures: Cognitive status was assessed using 6 clinic-administered cognitive tests: Montreal Cognitive Assessment (MoCA), Digit Symbol Substitution Test (DSST), Rey-Auditory Verbal Learning Test (RAVLT), Stroop, category fluency, and letter fluency. A global score measure derived using principal components analysis was also assessed; the first principal component explained 56% of variability.
      Results: Microbiome data were available on 597 CARDIA participants; mean (SD) age was 55.2 (3.5) years, 268 participants (44.7%) were men, and 270 (45.2%) were Black. In multivariable-adjusted principal coordinates analysis, permutational multivariate analysis of variance tests for β-diversity were statistically significant for all cognition measures (principal component analysis, P = .001; MoCA, P = .001; DSST, P = .001; RAVLT, P = .001; Stroop, P = .007; category fluency, P = .001) with the exception of letter fluency (P = .07). After adjusting for sociodemographic variables (age, race, sex, education), health behaviors (physical activity, diet, smoking, medication use), and clinical covariates (body mass index, diabetes, hypertension), Barnesiella was positively associated with the first principal component (β, 0.16; 95% CI, 0.08-0.24), DSST (β, 1.18; 95% CI, 0.35-2.00), and category fluency (β, 0.59; 95% CI, 0.31-0.87); Lachnospiraceae FCS020 group was positively associated with DSST (β, 2.67; 95% CI, 1.10-4.23), and Sutterella was negatively associated with MoCA (β, -0.27; 95% CI, -0.44 to -0.11).
      Conclusions and Relevance: In this cross-sectional study, microbial community composition, based on β-diversity, was associated with all cognitive measures in multivariable-adjusted analysis. These data contribute to a growing body of literature suggesting that the gut microbiota may be associated with cognitive aging, but must be replicated in larger samples and further researched to identify relevant pathways.
    • References:
      Nat Methods. 2016 Jul;13(7):581-3. (PMID: 27214047)
      J Med Chem. 2018 Jan 11;61(1):47-61. (PMID: 28745893)
      Hypertension. 2019 May;73(5):998-1006. (PMID: 30905192)
      Biosci Biotechnol Biochem. 2012;76(1):169-71. (PMID: 22232251)
      Inflamm Bowel Dis. 2008 Aug;14(8):1041-1050. (PMID: 18381614)
      Int J Obes (Lond). 2017 Jun;41(6):935-944. (PMID: 28220041)
      Br J Nutr. 2011 Aug;106(3):408-16. (PMID: 21342607)
      Circulation. 2016 Jun 14;133(24):2434-46. (PMID: 27143680)
      Psychopharmacology (Berl). 2011 Jun;215(4):677-87. (PMID: 21225418)
      Pharmacol Biochem Behav. 2015 Aug;135:53-9. (PMID: 26013850)
      Infect Immun. 2013 Mar;81(3):965-73. (PMID: 23319552)
      Front Microbiol. 2017 Sep 22;8:1765. (PMID: 29018410)
      Proc Natl Acad Sci U S A. 2014 Jun 3;111(22):E2329-38. (PMID: 24843156)
      Biomed Res Int. 2015;2015:412946. (PMID: 26523278)
      Gut. 2016 Mar;65(3):426-36. (PMID: 26100928)
      Appl Environ Microbiol. 2010 Feb;76(3):936-41. (PMID: 20008175)
      Am J Clin Nutr. 2012 Mar;95(3):580-6. (PMID: 22301926)
      Nat Rev Gastroenterol Hepatol. 2019 Aug;16(8):461-478. (PMID: 31123355)
      Sci Rep. 2015 Nov 13;5:16643. (PMID: 26563823)
      Nat Microbiol. 2018 Mar;3(3):347-355. (PMID: 29335554)
      J Neurosci. 2014 Nov 12;34(46):15490-6. (PMID: 25392516)
      Int Rev Neurobiol. 2016;131:227-246. (PMID: 27793221)
      Trends Cogn Sci. 2018 Jul;22(7):611-636. (PMID: 29907531)
      J Alzheimers Dis. 2011;26(1):187-97. (PMID: 21593570)
      Cell. 2017 Dec 14;171(7):1481-1493. (PMID: 29245010)
      Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6. (PMID: 23193283)
      Gut Microbes. 2020 Nov 9;12(1):1-14. (PMID: 32897773)
      PLoS One. 2013 Jul 16;8(7):e69621. (PMID: 23874976)
      Neuropsychopharmacology. 2019 Nov;44(12):2054-2064. (PMID: 31207607)
      Sci Rep. 2017 Sep 5;7(1):10411. (PMID: 28874832)
      J Cardiopulm Rehabil. 1989 Nov;9(11):448-459. (PMID: 29657358)
      J Int Neuropsychol Soc. 2017 Sep;23(8):700-705. (PMID: 28641593)
      Science. 2016 Apr 29;352(6285):560-4. (PMID: 27126039)
      Environ Microbiol. 2010 Feb;12(2):304-14. (PMID: 19807780)
      Proc Natl Acad Sci U S A. 2013 May 28;110(22):9066-71. (PMID: 23671105)
      J Clin Epidemiol. 1988;41(11):1105-16. (PMID: 3204420)
      PLoS One. 2012;7(4):e36095. (PMID: 22553482)
      ISME J. 2013 Nov;7(11):2116-25. (PMID: 23823492)
    • Grant Information:
      K01 HL127159 United States HL NHLBI NIH HHS; R01 AG063887 United States AG NIA NIH HHS; R35 AG071916 United States AG NIA NIH HHS
    • Publication Date:
      Date Created: 20220208 Date Completed: 20220228 Latest Revision: 20230717
    • Publication Date:
      20240628
    • Accession Number:
      PMC8826173
    • Accession Number:
      10.1001/jamanetworkopen.2021.43941
    • Accession Number:
      35133436